Professor of Neurosurgery
Harvard Medical School Brigham and Women's Hospital
Boston, MA, US
Dr. Alexandra J. Golby is a Neurosurgeon, Director of Image-guided Neurosurgery, Co-director of the Advanced Multi-modality Image guided OR (AMIGO), and Director of clinical fMRI at Brigham and Women’s Hospital in Boston. She is Professor of Neurosurgery and Professor of Radiology at Harvard Medical School. Dr. Golby holds the Haley Distinguished Chair in the Neurosciences at BWH. She is also Principal Investigator of the GolbyLab, a surgical brain mapping laboratory. Dr. Golby has special clinical interests in brain surgery for patients with brain tumors, especially those lesions which are intimately associated with critical brain structures. Dr. Golby has authored over 150 peer reviewed publications. Her translational research is focused on advanced imaging and image guidance to improve care for patients undergoing intracranial neurosurgery. She has developed numerous technologies to help guide presurgical planning and intraoperative decision making. She works closely with scientists across many disciplines including computer science, applied mathematics, MR and ultrasound physics, and biomedical engineering and is very involved with mentoring young clinicians and scientists. Dr. Golby was recently a Fulbright Global Scholar and helped foster interdisciplinary collaboration between technical experts and clinicians in host countries Rwanda and Morocco. She is also developing a low-cost, open source neuronavigation system for use in low resource settings and developing collaborations with neurosurgeons around the world to refine the technology and support education.
Disclosure(s): InSightec: Grant/Research Support (Terminated); Johnson & Johnson: Stock Shareholder (excluding mutual funds) (Ongoing); Merke: Stock Shareholder (excluding mutual funds) (Ongoing)
Comprehensive World Brain Mapping (Brain)
Friday, May 3, 2024
7:30 AM – 3:00 PM CT
fMRI Mapping for Speech and Sensorimotor Function
Friday, May 3, 2024
8:19 AM – 8:39 AM CT
Emerging Options for Glioma Patients
Saturday, May 4, 2024
1:30 PM – 3:00 PM CT
Case Presentation and Audience Poll mIDH Residual/Recurrent Glioma
Saturday, May 4, 2024
1:36 PM – 1:38 PM CT
Saturday, May 4, 2024
2:01 PM – 2:03 PM CT
Monday, May 6, 2024
7:00 AM – 12:00 PM CT
Monday, May 6, 2024
7:00 AM – 7:10 AM CT